Workplace productivity. A review of the impact of migraine and its treatment
- PMID: 11303412
- DOI: 10.2165/00019053-200119030-00002
Workplace productivity. A review of the impact of migraine and its treatment
Abstract
Migraine is a common disorder characterised by recurrent episodes of disability. Despite the high prevalence of migraine, data have been lacking on its impact in a working population. The advent of new therapies has stimulated interest in this area, and evidence is now available that documents the substantial impact of migraine on workplace productivity and the likelihood of untreated migraine leading to unemployment or underemployment for the patient. This paper reviews current findings of both observational and interventional studies about the impact of migraine on productivity and employment. When considered in the light of migraine demographics, the high prevalence of migraine, and its low consultation and treatment rates, this evidence indicates that improved screening and treatment for this common condition could have a substantial impact on worker productivity and on patient well-being.
Similar articles
-
Sumatriptan. A pharmacoeconomic review of its use in migraine.Pharmacoeconomics. 1997 May;11(5):473-90. doi: 10.2165/00019053-199711050-00009. Pharmacoeconomics. 1997. PMID: 10168035 Review.
-
The migraine ACE model: evaluating the impact on time lost and medical resource Use.Headache. 2000 Apr;40(4):282-91. doi: 10.1046/j.1526-4610.2000.00042.x. Headache. 2000. PMID: 10759932
-
The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.Curr Med Res Opin. 2004 Nov;20(11):1805-14. doi: 10.1185/030079904X10151. Curr Med Res Opin. 2004. PMID: 15537481
-
Working through a migraine: addressing the hidden costs of workplace headaches.AAOHN J. 2008 Dec;56(12):495-500; quiz 501-502. doi: 10.3928/08910162-20081201-02. AAOHN J. 2008. PMID: 19119716 Review.
-
Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.Mayo Clin Proc. 2000 Aug;75(8):782-9. doi: 10.4065/75.8.782. Mayo Clin Proc. 2000. PMID: 10943230 Clinical Trial.
Cited by
-
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire.J Headache Pain. 2018 Sep 10;19(1):85. doi: 10.1186/s10194-018-0914-7. J Headache Pain. 2018. PMID: 30203193 Free PMC article.
-
Validation of the work and health interview.Pharmacoeconomics. 2004;22(17):1127-40. doi: 10.2165/00019053-200422170-00003. Pharmacoeconomics. 2004. PMID: 15612831
-
CGRP receptor antagonists: A new frontier of anti-migraine medications.Drug Discov Today Ther Strateg. 2006 Winter;3(4):593-597. doi: 10.1016/j.ddstr.2006.11.003. Drug Discov Today Ther Strateg. 2006. PMID: 19784396 Free PMC article.
-
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process.Cephalalgia. 2022 Nov;42(13):1387-1396. doi: 10.1177/03331024221110102. Epub 2022 Jul 5. Cephalalgia. 2022. PMID: 35791285 Free PMC article. Review.
-
Hospital Burden of Migraine in United States Adults: A 15-year National Inpatient Sample Analysis.Plast Reconstr Surg Glob Open. 2020 Apr 23;8(4):e2790. doi: 10.1097/GOX.0000000000002790. eCollection 2020 Apr. Plast Reconstr Surg Glob Open. 2020. PMID: 32440450 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical